Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by UCB INC

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
010093 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
011613 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
013413 New Drug Application Approval New formulation (S) Standard review drug
014242 New Drug Application Approval New manufacturer (S) Standard review drug
017386 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
018050 New Drug Application Approval New manufacturer (S) Standard review drug
019111 New Drug Application Approval New combination (S) Standard review drug
019188 New Drug Application Approval New formulation (P) Priority review drug (V) Orphan drug
019401 New Drug Application Approval New ester, new salt, or other noncovalent derivative; New formulation (S) Standard review drug
019532 New Drug Application Approval New formulation (S) Standard review drug
020312 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020729 New Drug Application Approval New combination (S) Standard review drug
021035 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
021259 New Drug Application Approval New formulation (S) Standard review drug
021369 New Drug Application Approval New formulation (S) Standard review drug
021505 New Drug Application Approval New formulation (S) Standard review drug
021589 New Drug Application Approval New formulation (S) Standard review drug
021712 New Drug Application Approval New formulation (S) Standard review drug
021726 New Drug Application Approval New formulation (S) Standard review drug
021829 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
021872 New Drug Application Approval New formulation (S) Standard review drug
022064 New Drug Application Approval New manufacturer (P) Priority review drug
022157 New Drug Application Approval New formulation (S) Standard review drug
022253 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
022254 New Drug Application Approval New formulation (S) Standard review drug
022255 New Drug Application Approval New formulation (S) Standard review drug
022285 New Drug Application Approval New formulation (S) Standard review drug
040100 Abbreviated New Drug Application Approval
040134 Abbreviated New Drug Application Approval
040210 Abbreviated New Drug Application Approval
040306 Abbreviated New Drug Application Approval
073120 Abbreviated New Drug Application Approval
073121 Abbreviated New Drug Application Approval
076699 Abbreviated New Drug Application Approval
085171 Abbreviated New Drug Application Approval
085544 Abbreviated New Drug Application Approval
085799 Abbreviated New Drug Application Approval
085864 Abbreviated New Drug Application Approval
085935 Abbreviated New Drug Application Approval
085936 Abbreviated New Drug Application Approval
086335 Abbreviated New Drug Application Approval
086336 Abbreviated New Drug Application Approval
086337 Abbreviated New Drug Application Approval
086428 Abbreviated New Drug Application Approval
086429 Abbreviated New Drug Application Approval
087722 Abbreviated New Drug Application Approval
087757 Abbreviated New Drug Application Approval
089601 Abbreviated New Drug Application Approval
125160 Biologic License Application Approval
205836 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
205837 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
205838 New Drug Application Approval New molecular entity (NME) (S) Standard review drug

Back to Companies who have applied for FDA Drug Approval